Evidence map›Paper›PMID 41739474›Full record

ArticleJAMA network open2026

Plasma Biomarkers, Brain Volume, and Cognitive Performance in Service Members and Veterans With mTBI: A LIMBIC-CENC Study.

Heather E Dark, Kimbra Kenney, Nicola L de Souza, Carrie Esopenko, Katie A Edwards, Emily L Dennis, Mary R Newsome, Elisabeth A Wilde, Jessica M Gill

Abstract readMulticenter Study
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heather E DarkJohns Hopkins University School of Nursing, Baltimore, Maryland.
Kimbra KenneyDepartment of Neurology, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Nicola L de SouzaDepartment of Neurology, School of Medicine, University of Utah, Salt Lake City.
Carrie EsopenkoDepartment of Neurology, School of Medicine, University of Utah, Salt Lake City.
Katie A EdwardsJohns Hopkins University School of Nursing, Baltimore, Maryland.
Emily L DennisDepartment of Neurology, School of Medicine, University of Utah, Salt Lake City.
Mary R NewsomeDepartment of Neurology, School of Medicine, University of Utah, Salt Lake City.
Elisabeth A WildeDepartment of Neurology, School of Medicine, University of Utah, Salt Lake City.
Jessica M GillJohns Hopkins University School of Nursing, Baltimore, Maryland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Repetitive mild traumatic brain injury (mTBI) may result in neurobiological changes that contribute to persistent symptoms of cognitive dysfunction. Elevations in plasma biomarkers (glial fibrillary acidic protein [GFAP], neurofilament light chain [NfL], total-tau [t-tau], and ubiquitin C-terminal hydrolase-L1 [UCH-L1]) have been reported acutely after mTBI, but few studies have assessed these biomarkers during the chronic phase of mTBI. Objective: To examine whether the associations among plasma biomarkers, brain volume, and cognition varied by mTBI among US active-duty service members and veterans. Design, Setting, and Participants: This cross-sectional study used data from the Long-Term Impact of Military-Relevant Brain Injury Consortium-Chronic Effects of Neurotrauma Consortium (LIMBIC-CENC), a prospective, multicenter study of US active-duty service members and veterans (SMVs). Data collection began in January 2015, and only enrollment data (collected 2015 to September 2023) were analyzed. Recruitment occurred across several different VA medical centers and military sites across the United States. Participants were aged 18 years or older; had a history of deployment in Operation Enduring Freedom, Operation Iraqi Freedom, or Operation New Dawn; and had combat exposure during deployment. Exclusion criteria were major neurologic or psychiatric disorder, history of moderate to severe TBI, coma lasting more than 30 minutes, posttraumatic amnesia lasting more than 24 hours, and intracranial lesion on computed tomography scan. Exposure: History of blast- or combat-related mTBI. Main Outcomes and Measures: Plasma biomarkers were analyzed using Quanterix SIMOA assays. History of mTBI was ascertained using structured clinical interview. Regional brain volume was derived from T1-weighted magnetic resonance imaging scans. Cognitive performance was assessed using neuropsychological measures. Correlations were computed for associations between mTBI, brain volume, and cognition, and separate covariate-adjusted linear regression models we used to examine the association between each plasma biomarker and brain volume as well as cognition. Additional linear regression models were used to examine whether the number of combat-related and blast-related mTBIs moderated the association between each plasma biomarker, brain volume, and cognition. Results: The cohort included 1160 participants (mean [SD] age, 41.9 [10.2] years; 1025 [88.4%] male; mean [SD] years since last mTBI, 12.1 [9.5]). Less than half of the sample was exposed to at least 1 blast-related (475 [40.9%]) or combat-related mTBI (490 [42.2%]). The association between enrollment biomarker concentration and brain volume and cognitive performance differed by the number of mTBIs. Among those with 2 mTBIs, higher UCH-L1 concentrations were associated with smaller anterior cingulate volume (blast-related mTBI: b = -0.08; 95% CI, -0.16 to -0.01; P = .04; combat-related mTBI: b = -0.09; 95% CI, -0.17 to -0.01; P = .03). Among those with 2 blast-related mTBIs, higher t-tau was associated with poorer performance on immediate and delayed visual memory (eg, performance on the Brief Visuospatial Memory Test-Revised, immediate recall: b = -0.11; 95% CI, -0.19 to -0.04; P = .003; delayed recall: b = -0.08; 95% CI, -0.16 to -0.01; P = .03), and higher GFAP and NfL concentration were associated with worse executive functioning (performance on Trail Making Testing B: GFAP concentration: b = 0.20; 95% CI, 0.03 to 0.37; P = .02; NfL concentration, b = 0.14; 95% CI, 0.01 to 0.26; P = .04), while no biomarker-cognition associations were observed for those with no mTBIs. However, most findings did not pass multiple comparison correction and should be interpreted with caution. Conclusions and Relevance: In this cross-sectional study of 1160 SMVs, plasma biomarkers of neuronal injury and astrogliosis were associated with brain volume and cognitive performance based on mTBI.

Indexed as

BiomarkersBrainBrain ConcussionCognitionMilitary PersonnelVeteransAdultCross-Sectional StudiesFemaleGlial Fibrillary Acidic ProteinHumansMaleNeurofilament ProteinsProspective StudiesUnited StatesBiomarkersGlial Fibrillary Acidic ProteinNeurofilament Proteins

Identifiers

PMID41739474
PMCPMC12936882

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.